Skip to main content

#Influenza and Other Respiratory Viruses Research #References (by AMEDEO, Dec. 28 ' 24)

Image
By G.M.


 

    Antiviral Res

  1. WANG B, Xia H, Peng BH, Choi EJ, et al
    Pellino-1, a therapeutic target for control of SARS-CoV-2 infection and disease severity.
    Antiviral Res. 2024;233:106059.
    PubMed         Abstract available

  2. SCHRELL L, Fuchs HL, Dickmanns A, Scheibner D, et al
    Inhibitors of dihydroorotate dehydrogenase synergize with the broad antiviral activity of 4'-fluorouridine.
    Antiviral Res. 2024 Dec 3:106046. doi: 10.1016/j.antiviral.2024.106046.
    PubMed         Abstract available


    Epidemiol Infect

  3. SUTER J, Devos I, Matthes KL, Staub K, et al
    The health and demographic impacts of the "Russian flu" pandemic in Switzerland in 1889/1890 and in the years thereafter.
    Epidemiol Infect. 2024;152:e174.
    PubMed         Abstract available


    JAMA

  4. ANDERER S
    CDC Calls Attention to Underuse of Antiviral Treatment in Higher-Risk Youth With Influenza.
    JAMA. 2024 Dec 27. doi: 10.1001/jama.2024.25515.
    PubMed        


    PLoS Comput Biol

  5. CALMON L, Colosi E, Bassignana G, Barrat A, et al
    Preserving friendships in school contacts: An algorithm to construct synthetic temporal networks for epidemic modelling.
    PLoS Comput Biol. 2024;20:e1012661.
    PubMed         Abstract available


    PLoS One

  6. BAGALA I, Namuganga JF, Nayebare P, Cuu G, et al
    Seroprevalence of SARS-CoV-2 and risk factors for infection among children in Uganda: A serial cross-sectional study.
    PLoS One. 2024;19:e0312554.
    PubMed         Abstract available

  7. ZHANG Y, Guo X, Su Y
    Spatiotemporal dynamic and regional differences of public attention to vaccination: An empirical study in China.
    PLoS One. 2024;19:e0312488.
    PubMed         Abstract available

  8. KIM S, Aum T, Lee DG
    Depression in the COVID-19 endemic era: Analysis of online self-disclosures by young South Koreans.
    PLoS One. 2024;19:e0314881.
    PubMed         Abstract available

  9. OPOKU-BOATENG YN, Opoku-Asante E, Lagarde M, Nketiah-Amponsah E, et al
    Effect of Covid-19 on maternal and child health services utilization in Ghana. Evidence from the National Health Insurance Scheme (NHIS).
    PLoS One. 2024;19:e0311277.
    PubMed         Abstract available

  10. TARIGAN S, Sekarmila G, Apas, Sumarningsih, et al
    Challenges and strategies in the soluble expression of CTA1-(S14P5)4-DD and CTA1-(S21P2)4-DD fusion proteins as candidates for COVID-19 intranasal vaccines.
    PLoS One. 2024;19:e0306153.
    PubMed         Abstract available

  11. VALDERRAMA-BELTRAN SL, Cuervo-Rojas J, Rondon M, Montealegre-Diaz JS, et al
    Development of a diagnostic multivariable prediction model of a positive SARS-CoV-2 RT-PCR result in healthcare workers with suspected SARS-CoV-2 infection in hospital settings.
    PLoS One. 2024;19:e0316207.
    PubMed         Abstract available

  12. JIMENEZ-CAMPOS AG, Maestas LI, Velappan N, Beck B, et al
    A cell-based Papain-like Protease (PLpro) activity assay for rapid detection of active SARS-CoV-2 infections and antivirals.
    PLoS One. 2024;19:e0309305.
    PubMed         Abstract available

  13. FENTA EH, Tassew B, Abera A, Wolde FB, et al
    Maintaining essential healthcare services in Addis Ababa during COVID-19: A qualitative study.
    PLoS One. 2024;19:e0308534.
    PubMed         Abstract available

  14. HUI CY, Condon K, Kolekar S, Roberts N, et al
    Implementing digital respiratory technologies for people with respiratory conditions: A protocol for a scoping review.
    PLoS One. 2024;19:e0314914.
    PubMed         Abstract available

  15. SCHICK RC, Bast H, Frank M, Urban T, et al
    Simulated low-dose dark-field radiography for detection of COVID-19 pneumonia.
    PLoS One. 2024;19:e0316104.
    PubMed         Abstract available

  16. ROMASZKO-WOJTOWICZ A, Doboszynska A, Piechnik A, Kuziemski K, et al
    Impact of the COVID-19 pandemic on lung cancer diagnosis in northern Poland-addressing the COVID-19 debt.
    PLoS One. 2024;19:e0316261.
    PubMed         Abstract available

  17. ALI MA, Shaker OG, Ezzat EM, Ali ESG, et al
    Peripheral lncRNA NEAT-1, miR374b-5p, and IL6 panel to guide in COVID-19 patients' diagnosis and prognosis.
    PLoS One. 2024;19:e0313042.
    PubMed         Abstract available

  18. HADID D, Correia RH, McDonald SD, Darling EK, et al
    Assessing the impact of the COVID-19 pandemic on uptake and experiences of gestational diabetes mellitus screening in Ontario: A parallel convergent mixed-methods study.
    PLoS One. 2024;19:e0315983.
    PubMed         Abstract available


    Vaccine

  19. WANG J, Tonnies T, Brinks R
    Seasonal influenza vaccination coverage and the social determinants of influenza vaccination among people over 50 with diabetes in Europe: Analyzing population-based SHARE data for the 2019-2020 and 2021-2022 influenza seasons.
    Vaccine. 2024;45:126646.
    PubMed         Abstract available

  20. FRAIHA ALS, da Silva Santos BSA, Aguilar NR, Gallinari GC, et al
    Immunization and challenge trials in a murine model using different inactivated recombinant vaccines against H1N1 swine influenza virus circulating in Brazil.
    Vaccine. 2024;45:126638.
    PubMed         Abstract available

  21. WERTHNER Q, Faehrmann L, Och K, Bragazzi NL, et al
    Client satisfaction, safety, and insights from a three-season survey on influenza vaccinations delivered at community pharmacies in Germany.
    Vaccine. 2024;45:126650.
    PubMed         Abstract available
Labels:

Comments

Post a Comment

Popular posts from this blog

#Neuroinvasive #Oropouche virus in a patient with #HIV from extra-Amazonian #Brazil

By G.M.
{Excerpt} A novel reassortant Oropouche virus (OROV) lineage (with medium [M], large [L], and small [S] RNA segments : M1L2S2) has driven Brazil's largest and most geographically widespread OROV epidemic , expanding beyond the endemic Amazon basin to establish local transmission across multiple Brazilian states and other previously unaffected Latin American countries . The rapid spread of this lineage underscores its evolutionary potential and reinforces its significance as a public health threat .1 Similar to chikungunya and Zika viruses, expanding arboviruses can exhibit unexpected clinical and epidemiological shifts , including vertical transmissions , neuroinvasive effects, and potentially fatal outcomes.2–4 Although OROV typically causes self-limited febrile illness, accumulating clinical and experimental evidence suggests neurotropic potential .5 This Correspondence describes the first confirmed case of neuroinvasive OROV infection caused by the emergent M1L2S2 lineage in ext...
Post a Comment
Read more »

No evidence of immune #exhaustion after repeated #SARS-CoV-2 #vaccination in vulnerable and healthy populations

By G.M.
Abstract Frequent SARS-CoV-2 vaccination in vulnerable populations has raised concerns that this may contribute to T cell exhaustion , which could negatively affect the quality of immune protection. Herein, we examined the impact of repeated SARS-CoV-2 vaccination on T cell phenotypic and functional exhaustion in frail older adults in long-term care (n = 23), individuals on immunosuppressive drugs (n = 10), and healthy adults (n = 43), in Canada . Spike-specific CD4+ and CD8+ T cell levels did not decline in any cohort following repeated SARS-CoV-2 vaccination, nor did the expression of exhaustion markers on spike-specific or total T cells increase. T cell production of multiple cytokines (i.e. polyfunctionality) in response to the spike protein of SARS-CoV-2 did not decline in any cohort following repeated vaccination. None of the cohorts displayed elevated levels of terminally differentiated T cells following multiple SARS-CoV-2 vaccinations. Thus, repeated SARS-CoV-2 vaccination was...
Post a Comment
Read more »

Chimeric #hemagglutinin and #M2 #mRNA #vaccine for broad #influenza subtype protection

By G.M.
Abstract Since multiple and unpredicted influenza viruses cause seasonal epidemics and even high-risk pandemics , developing a universal influenza vaccine is essential to provide broad protection against various influenza subtypes. Combined with the mRNA lipid nanoparticle-encapsulated (mRNA-LNP) vaccine platform and chimeric immunogen strategy , we developed a novel cocktail mRNA vaccine encoding chimeric HAs (cH5/1-BV, cH7/3) and intact M2 (termed Fluaxe), which confers broad protection against major circulating IAVs and IBVs , as well as highly pathogenic avian influenza . Two-dose intramuscular immunization of Fluaxe in mice elicited cross-reactive neutralizing antibodies , T cell responses, and long-lived immunity, resulting in robust protection against multiple lethal influenza virus infections and severe acute lung injuries . In particular, intramuscular administration stimulated systemic immunity together with a prominent lung tropism of memory cells . Moreover, Fluaxe immuniza...
Post a Comment
Read more »